Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 20, 2015 16:02 ET | Source: CollabRx, Inc.

CollabRx Receives NASDAQ Listing Determination; Intends to Request Hearing

SAN FRANCISCO, Jan. 20, 2015 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) ("the Company") announced that it received a letter from the NASDAQ Listing Qualifications Staff indicating that, unless...
December 03, 2014 16:01 ET | Source: CollabRx, Inc.

CollabRx Announces Receipt of NASDAQ Notice of Non-Compliance With Rule 5550(b)(1)

SAN FRANCISCO, Dec. 3, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company"), announced today that it received a letter from the NASDAQ OMX GROUP ("Nasdaq") stating...
November 24, 2014 07:01 ET | Source: CollabRx, Inc.

CollabRx Announces Receipt of NASDAQ Notice of Bid Price Deficiency

SAN FRANCISCO, Nov. 24, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq:CLRX) (herein "CLRX" or "the Company"), announced today that it received a letter from the NASDAQ OMX GROUP ("Nasdaq") stating...
November 13, 2014 16:00 ET | Source: CollabRx, Inc.

CollabRx Reports Second Quarter Fiscal Year 2015 Financial Results

SAN FRANCISCO, Nov. 13, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) announces financial results and business highlights for the second quarter of fiscal year 2015, which...
November 10, 2014 09:02 ET | Source: CollabRx, Inc.

CollabRx and Cartagenia Partner in Interpretation Support and Reporting of Genetic Sequencing-Based Tests for Cancer

SAN FRANCISCO, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX) today announced a partnership with Cartagenia, Inc. to provide and promote to the clinical laboratory...
November 05, 2014 09:01 ET | Source: CollabRx, Inc.

CollabRx and Collaborators at Leading Academic Centers Publish Clinical Decision Support Model for Precision Oncology

SAN FRANCISCO, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (Nasdaq:CLRX), a leading provider of clinical decision support solutions in oncology, today announced the publication...
October 17, 2014 09:01 ET | Source: CollabRx, Inc.

CollabRx Editor-in-Chief & CMO George D. Lundberg, MD Wins 2014 ASCP Ward Burdick Award for Distinguished Service to Pathology

SAN FRANCISCO, Calif., Oct. 17, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (Nasdaq:CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology,...
September 11, 2014 09:04 ET | Source: CollabRx, Inc.

CollabRx Launches Expansion of Its Genetic Variation Annotation Service to Support Copy Number Variation (CNV) Data

SAN FRANCISCO, Calif., Sept. 11, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX), a leading provider of software and IT systems that support clinical decision-making in oncology,...
August 14, 2014 16:00 ET | Source: CollabRx, Inc.

CollabRx Reports First Quarter Fiscal Year 2015 Financial Results

SAN FRANCISCO, Aug. 14, 2014 (GLOBE NEWSWIRE) -- CollabRx, Inc. (the "Company") (Nasdaq:CLRX) announces financial results and business highlights for the first quarter of fiscal year 2015, which ended...
July 31, 2014 09:03 ET | Source: CollabRx, Inc.

CollabRx, Inc. Schedules First Quarter Fiscal Year 2015 Financial Conference Call and Business Update

SAN FRANCISCO, Calif., July 31, 2014 (GLOBE NEWSWIRE) -- via PRWEB - CollabRx, Inc. (NASDAQ: CLRX), a leading provider of expert systems that inform therapeutic decision-making in oncology, today...